Global /South Korea /Healthcare /Drug Manufacturers - General /235980

MedPacto, Inc.

235980

• KRX: 235980 • Delayed

5,120KRW -3%

3.37 USD

As of 15 June 2026, MedPacto, Inc. has a market cap of $119.22M USD, ranking #24341 globally and #1119 in South Korea. It ranks #2175 in the Healthcare sector, and #789 in the Drug Manufacturers - General industry.

Global Rank

24341

Country Rank

1119

Sector Rank

2175

Industry Rank

789

Key Stats

Market Cap

$119.22MUSD

180.97B KRW

Enterprise Value

$93.54MUSD

142.0B KRW

Revenue (TTM)

$2.57MUSD

3.9B KRW

EBITDA (TTM)

-$8.49MUSD

-12.89B KRW

Net Income (TTM)

-$8.44MUSD

-12.81B KRW

PS Ratio

46.4

PB Ratio

3.9

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Seong-Jin Kim open_in_new

Founded

2013

Website

medpacto.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3%	4.3%	-13%	-22%	24%	-21%	63%	-76%	-93%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	235980 (주)메드팩토 Ordinary Shares ISIN: KR7235980000 Shares Out.: Shares Outstanding: 34.275M¹ Shares Float: 24.789M² TV: TradingView: KRX: 235980 SA: Stock Analysis: KRX: 235980 YF: Yahoo Finance: 235980.KS GF: Google Finance: KRX: 235980 BA: Barron's: 235980 MS: Morningstar: XKRX: 235980	5,120 KRW	TV: TradingView: KRX: 235980 SA: Stock Analysis: KRX: 235980 YF: Yahoo Finance: 235980.KS GF: Google Finance: KRX: 235980 BA: Barron's: 235980 MS: Morningstar: XKRX: 235980

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About MedPacto, Inc.

MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.16B 13.91T KRW 8K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.79B 10.3T KRW 6K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.25B 7.97T KRW 4K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.97B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.56B 6.92T KRW 4K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.45B 6.76T KRW 4K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 639K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 459K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 302K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 270K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 242K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 230K%	20.5	Switzerland

chevron_leftBack